Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β-agonist fixed-dose combinations in COPD

Background: Dual bronchodilation with a long-acting muscarinic antagonist (LAMA)/long-acting β 2 -agonist (LABA) fixed-dose combination (FDC) is an established treatment strategy for chronic obstructive pulmonary disease (COPD). The relative efficacy and safety of glycopyrrolate/formoterol fumarate...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Mohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins, Mario Ouwens, Deniz Guranlioglu, Patrick Darken, Mousumi Biswas
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: SAGE Publishing 2019-12-01
Sarja:Therapeutic Advances in Respiratory Disease
Linkit:https://doi.org/10.1177/1753466619894502
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia